Sera Prognostics Q3 net loss widens to $8.05 million; revenue more than doubles to $42,000
SERA•SERA•SERA•SERA•Sera Prognostics’ third-quarter 2026 net loss widened year over year to $8.05 million, while revenue more than doubled to $42,000. Operating expenses fell 11% from the second quarter to $8.93 million, and Florida became the second state to provide Medicaid coverage for PreTRM.
Sera Prognostics reported a third-quarter 2026 net loss of $8.05 million, wider than a year earlier. Revenue more than doubled year over year to $42,000, while a higher mix of low- or non-reimbursed tests pressured average selling prices.
Operating expenses fell 11% from the second quarter to $8.93 million following cost reductions implemented in June. Florida became the second state providing Medicaid coverage for PreTRM, bringing total covered Medicaid lives to approximately 7 million.
